Citation

BibTex format

@inproceedings{Curry:2015:10.1158/1538-8514.PI3K14-A47,
author = {Curry, E and Cheraghchi-Bashi-Astaneh, A and Chen, M and Cunnea, P and Camila, DS and Maginn, E and Dai, Y and Liu, E and Wasan, H and Mills, GB and Bowtell, D and Gabra, H and Stronach, EA},
doi = {10.1158/1538-8514.PI3K14-A47},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway},
url = {http://dx.doi.org/10.1158/1538-8514.PI3K14-A47},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Curry,E
AU - Cheraghchi-Bashi-Astaneh,A
AU - Chen,M
AU - Cunnea,P
AU - Camila,DS
AU - Maginn,E
AU - Dai,Y
AU - Liu,E
AU - Wasan,H
AU - Mills,GB
AU - Bowtell,D
AU - Gabra,H
AU - Stronach,EA
DO - 10.1158/1538-8514.PI3K14-A47
PB - AMER ASSOC CANCER RESEARCH
PY - 2015///
SN - 1535-7163
TI - DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway
UR - http://dx.doi.org/10.1158/1538-8514.PI3K14-A47
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358159200039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
ER -